

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * complement activation (GO:0006956) | 8.92211419 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.75553511 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.72384545 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.72384545 |
| 5 | negative regulation of glucose import (GO:0046325) | 7.62601087 |
| 6 | B cell receptor signaling pathway (GO:0050853) | 7.34564714 |
| 7 | cytidine metabolic process (GO:0046087) | 6.82085582 |
| 8 | cytidine catabolic process (GO:0006216) | 6.82085582 |
| 9 | cytidine deamination (GO:0009972) | 6.82085582 |
| 10 | positive regulation of respiratory burst (GO:0060267) | 6.73107220 |
| 11 | signal peptide processing (GO:0006465) | 6.53247036 |
| 12 | negative regulation of glucose transport (GO:0010829) | 6.15054862 |
| 13 | negative regulation of B cell proliferation (GO:0030889) | 6.14019023 |
| 14 | * immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.03934369 |
| 15 | * Fc-gamma receptor signaling pathway (GO:0038094) | 6.03934369 |
| 16 | * Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.03934369 |
| 17 | * Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.94981766 |
| 18 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.87170080 |
| 19 | * protein activation cascade (GO:0072376) | 5.68407792 |
| 20 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.61678366 |
| 21 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.61678366 |
| 22 | * humoral immune response (GO:0006959) | 5.58441643 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.51771795 |
| 24 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.36750350 |
| 25 | regulation of B cell proliferation (GO:0030888) | 5.33944734 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 5.24966435 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 5.23698492 |
| 28 | T cell migration (GO:0072678) | 5.23161759 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.12825892 |
| 30 | regulation of B cell differentiation (GO:0045577) | 5.03279268 |
| 31 | glomerular filtration (GO:0003094) | 4.98057233 |
| 32 | retina homeostasis (GO:0001895) | 4.97449187 |
| 33 | cellular response to zinc ion (GO:0071294) | 4.87021031 |
| 34 | negative regulation of bone resorption (GO:0045779) | 4.65124346 |
| 35 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.62864232 |
| 36 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.55296880 |
| 37 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.45042515 |
| 38 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.43267669 |
| 39 | renal filtration (GO:0097205) | 4.42259950 |
| 40 | regulation of respiratory burst (GO:0060263) | 4.41857460 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 4.36384304 |
| 42 | B cell proliferation (GO:0042100) | 4.30168981 |
| 43 | positive regulation of immunoglobulin production (GO:0002639) | 4.27708405 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.27632791 |
| 45 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.23472920 |
| 46 | mature B cell differentiation (GO:0002335) | 4.22843030 |
| 47 | antimicrobial humoral response (GO:0019730) | 4.16174045 |
| 48 | antibacterial humoral response (GO:0019731) | 4.14973932 |
| 49 | hepatocyte apoptotic process (GO:0097284) | 4.09881530 |
| 50 | keratinization (GO:0031424) | 4.06406542 |
| 51 | defense response to protozoan (GO:0042832) | 4.02530329 |
| 52 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.95632555 |
| 53 | cellular extravasation (GO:0045123) | 3.95293226 |
| 54 | mannose metabolic process (GO:0006013) | 3.93431686 |
| 55 | apoptotic cell clearance (GO:0043277) | 3.91808882 |
| 56 | dendritic cell chemotaxis (GO:0002407) | 3.87614793 |
| 57 | protein retention in ER lumen (GO:0006621) | 3.81088132 |
| 58 | positive regulation of Rap GTPase activity (GO:0032854) | 3.80737080 |
| 59 | myeloid dendritic cell activation (GO:0001773) | 3.79605825 |
| 60 | regulation of B cell activation (GO:0050864) | 3.79181000 |
| 61 | mature B cell differentiation involved in immune response (GO:0002313) | 3.74554222 |
| 62 | regulation of cellular extravasation (GO:0002691) | 3.72884654 |
| 63 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.70133415 |
| 64 | regulation of B cell apoptotic process (GO:0002902) | 3.67569141 |
| 65 | lymphocyte migration (GO:0072676) | 3.64652064 |
| 66 | L-fucose catabolic process (GO:0042355) | 3.62961553 |
| 67 | fucose catabolic process (GO:0019317) | 3.62961553 |
| 68 | L-fucose metabolic process (GO:0042354) | 3.62961553 |
| 69 | lymphocyte chemotaxis (GO:0048247) | 3.62375913 |
| 70 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.60694196 |
| 71 | respiratory burst (GO:0045730) | 3.59766021 |
| 72 | negative regulation of bone remodeling (GO:0046851) | 3.58349282 |
| 73 | B cell homeostasis (GO:0001782) | 3.56765948 |
| 74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.48923275 |
| 75 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.48338419 |
| 76 | natural killer cell mediated immunity (GO:0002228) | 3.48338419 |
| 77 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.46978814 |
| 78 | regulation of fibroblast apoptotic process (GO:2000269) | 3.46742751 |
| 79 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.46735583 |
| 80 | positive regulation of nuclease activity (GO:0032075) | 3.44234492 |
| 81 | response to interferon-alpha (GO:0035455) | 3.43467033 |
| 82 | regulation of nuclease activity (GO:0032069) | 3.42018213 |
| 83 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.39199172 |
| 84 | leukocyte tethering or rolling (GO:0050901) | 3.39010128 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.38860366 |
| 86 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.38759971 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36741501 |
| 88 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.35796189 |
| 89 | peptidyl-asparagine modification (GO:0018196) | 3.35306627 |
| 90 | cellular response to unfolded protein (GO:0034620) | 3.31920470 |
| 91 | multicellular organismal water homeostasis (GO:0050891) | 3.31121781 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30430606 |
| 93 | GDP-mannose metabolic process (GO:0019673) | 3.27815372 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.27799719 |
| 95 | B cell activation (GO:0042113) | 3.26822512 |
| 96 | response to protozoan (GO:0001562) | 3.25936952 |
| 97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25118227 |
| 98 | regulation of immunoglobulin production (GO:0002637) | 3.23694447 |
| 99 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.23513864 |
| 100 | exocrine pancreas development (GO:0031017) | 3.23504420 |
| 101 | detection of bacterium (GO:0016045) | 3.23208371 |
| 102 | cellular response to type I interferon (GO:0071357) | 3.22847929 |
| 103 | type I interferon signaling pathway (GO:0060337) | 3.22847929 |
| 104 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 3.22739734 |
| 105 | response to type I interferon (GO:0034340) | 3.21740010 |
| 106 | negative regulation of B cell activation (GO:0050869) | 3.19843458 |
| 107 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.19636776 |
| 108 | germinal center formation (GO:0002467) | 3.19543155 |
| 109 | dendritic cell differentiation (GO:0097028) | 3.19132983 |
| 110 | cellular response to antibiotic (GO:0071236) | 3.18104214 |
| 111 | response to endoplasmic reticulum stress (GO:0034976) | 3.17891171 |
| 112 | response to hydroperoxide (GO:0033194) | 3.17816668 |
| 113 | * immune response-activating signal transduction (GO:0002757) | 3.16303049 |
| 114 | regulation of Rap GTPase activity (GO:0032317) | 3.15356963 |
| 115 | cellular response to virus (GO:0098586) | 3.13098023 |
| 116 | mitochondrion distribution (GO:0048311) | 3.11804462 |
| 117 | protein N-linked glycosylation (GO:0006487) | 3.11320833 |
| 118 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11292930 |
| 119 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.10323986 |
| 120 | cellular response to topologically incorrect protein (GO:0035967) | 3.09037335 |
| 121 | somatic diversification of immunoglobulins (GO:0016445) | 3.08659957 |
| 122 | negative regulation of B cell apoptotic process (GO:0002903) | 3.07437327 |
| 123 | negative regulation of gene silencing (GO:0060969) | 3.06347501 |
| 124 | detection of other organism (GO:0098543) | 3.05978506 |
| 125 | negative regulation of tissue remodeling (GO:0034104) | 3.05358692 |
| 126 | positive regulation of B cell proliferation (GO:0030890) | 3.05161796 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04133576 |
| 128 | ER-nucleus signaling pathway (GO:0006984) | 3.02833104 |
| 129 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00961655 |
| 130 | positive regulation of B cell activation (GO:0050871) | 3.00763537 |
| 131 | B cell activation involved in immune response (GO:0002312) | 3.00733502 |
| 132 | positive regulation of protein homooligomerization (GO:0032464) | 3.00692566 |
| 133 | angiotensin maturation (GO:0002003) | 3.00329839 |
| 134 | regulation of necroptotic process (GO:0060544) | 2.97205766 |
| 135 | mitochondrial calcium ion transport (GO:0006851) | 2.94707650 |
| 136 | negative thymic T cell selection (GO:0045060) | 2.93594997 |
| 137 | cell redox homeostasis (GO:0045454) | 2.92415797 |
| 138 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.90248598 |
| 139 | L-serine transport (GO:0015825) | 2.90199060 |
| 140 | regulation of antigen processing and presentation (GO:0002577) | 2.89053836 |
| 141 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89024487 |
| 142 | lymphocyte homeostasis (GO:0002260) | 2.88812792 |
| 143 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.88554319 |
| 144 | defense response to Gram-negative bacterium (GO:0050829) | 2.88548625 |
| 145 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.88377860 |
| 146 | negative regulation of necroptotic process (GO:0060546) | 2.88359045 |
| 147 | modulation by virus of host process (GO:0019054) | 2.88213156 |
| 148 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.88016710 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87584884 |
| 150 | post-embryonic morphogenesis (GO:0009886) | 2.87466217 |
| 151 | regulation of necrotic cell death (GO:0010939) | 2.87356890 |
| 152 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85947464 |
| 153 | * activation of immune response (GO:0002253) | 2.84770797 |
| 154 | dendritic cell migration (GO:0036336) | 2.83882095 |
| 155 | COPI coating of Golgi vesicle (GO:0048205) | 2.83729507 |
| 156 | keratinocyte differentiation (GO:0030216) | 2.82392025 |
| 157 | regulation of water loss via skin (GO:0033561) | 2.80413505 |
| 158 | amyloid precursor protein metabolic process (GO:0042982) | 2.80353200 |
| 159 | positive regulation of T cell migration (GO:2000406) | 2.78640888 |
| 160 | modulation by symbiont of host cellular process (GO:0044068) | 2.78300403 |
| 161 | positive regulation of lymphocyte migration (GO:2000403) | 2.77606321 |
| 162 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.77149205 |
| 163 | adhesion of symbiont to host cell (GO:0044650) | 2.76908092 |
| 164 | * complement activation, classical pathway (GO:0006958) | 11.7515342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.12257967 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.41179246 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.85352967 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.41703313 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.99841362 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.99459521 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98439301 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.90414151 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.38561668 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20222964 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.95069476 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86564132 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78299610 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69560183 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67260467 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.60271559 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.49012052 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48855995 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48550896 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.33235077 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.30851313 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23457722 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.15993305 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15817490 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.15158941 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03073341 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01768887 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97664912 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92954510 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90500282 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89361405 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85007096 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84742135 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81479388 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78602156 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76886874 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75771408 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72129671 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68361844 |
| 40 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67126416 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66182609 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61833949 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61639942 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60584282 |
| 45 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.59960424 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.58252900 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57469746 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57065127 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55830299 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54841032 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54422408 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47471891 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47234542 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.47133087 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45739086 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45634299 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40819929 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37493578 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36824544 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36248439 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35462082 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32284418 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30529574 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27400610 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27050945 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25624304 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24081622 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24012319 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23501144 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23400649 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22872854 |
| 72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21278313 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21255371 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20866737 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20573594 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20499561 |
| 77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19003801 |
| 78 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.18719132 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18546272 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16665430 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15827210 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11406743 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10893654 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10404827 |
| 85 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07689997 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06830252 |
| 87 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06540548 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06143588 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06099000 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05927357 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05446169 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04860317 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04461682 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04140226 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03718957 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03317752 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02404843 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99823027 |
| 99 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99266443 |
| 100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96918298 |
| 101 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96122606 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96046421 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94956085 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94945405 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94062918 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93850318 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93776770 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93238108 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92863872 |
| 110 | P300_27268052_Chip-Seq_Bcells_Human | 0.90898114 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90667565 |
| 112 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.88757371 |
| 113 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.88739513 |
| 114 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88585569 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.87254689 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.86487023 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85867360 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85513163 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85212743 |
| 120 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85070370 |
| 121 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84778934 |
| 122 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.83844081 |
| 123 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.83013795 |
| 124 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82576358 |
| 125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82355530 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82206978 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81442955 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81402247 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79838480 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79760491 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79348038 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77742990 |
| 133 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75924648 |
| 134 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75551020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.35703701 |
| 2 | MP0001800_abnormal_humoral_immune | 5.02482408 |
| 3 | MP0003303_peritoneal_inflammation | 4.44394437 |
| 4 | MP0001790_abnormal_immune_system | 4.39386549 |
| 5 | MP0005387_immune_system_phenotype | 4.39386549 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.78644570 |
| 7 | MP0005671_abnormal_response_to | 3.59436199 |
| 8 | MP0000685_abnormal_immune_system | 3.18087913 |
| 9 | MP0002723_abnormal_immune_serum | 3.14759484 |
| 10 | MP0002420_abnormal_adaptive_immunity | 3.05481521 |
| 11 | MP0001819_abnormal_immune_cell | 2.98696469 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.95518397 |
| 13 | * MP0002398_abnormal_bone_marrow | 2.72337544 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.68150848 |
| 15 | * MP0000716_abnormal_immune_system | 2.60619564 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.57829877 |
| 17 | MP0000689_abnormal_spleen_morphology | 2.57444192 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 2.49280285 |
| 19 | MP0005025_abnormal_response_to | 2.38350841 |
| 20 | MP0002796_impaired_skin_barrier | 2.35300173 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.29930485 |
| 22 | MP0003724_increased_susceptibility_to | 2.29397465 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.23544608 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.23175139 |
| 25 | * MP0002429_abnormal_blood_cell | 2.17752364 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.09304008 |
| 27 | MP0002722_abnormal_immune_system | 2.09293947 |
| 28 | MP0004043_abnormal_pH_regulation | 1.96906111 |
| 29 | MP0003436_decreased_susceptibility_to | 1.91481802 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.88568222 |
| 31 | MP0009785_altered_susceptibility_to | 1.87762391 |
| 32 | MP0006054_spinal_hemorrhage | 1.87277056 |
| 33 | MP0002419_abnormal_innate_immunity | 1.83305774 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.81456094 |
| 35 | MP0009840_abnormal_foam_cell | 1.80467431 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.80270112 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.69311485 |
| 38 | MP0002933_joint_inflammation | 1.65095468 |
| 39 | MP0002006_tumorigenesis | 1.64489155 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.61884477 |
| 41 | MP0005275_abnormal_skin_tensile | 1.59882765 |
| 42 | MP0004947_skin_inflammation | 1.58877509 |
| 43 | MP0010307_abnormal_tumor_latency | 1.55891794 |
| 44 | MP0005310_abnormal_salivary_gland | 1.54372308 |
| 45 | MP0005451_abnormal_body_composition | 1.52921815 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.50049129 |
| 47 | MP0002405_respiratory_system_inflammati | 1.44072910 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.41660492 |
| 49 | MP0004510_myositis | 1.40073375 |
| 50 | MP0001853_heart_inflammation | 1.37855685 |
| 51 | MP0001873_stomach_inflammation | 1.35344928 |
| 52 | MP0003866_abnormal_defecation | 1.33876640 |
| 53 | MP0004858_abnormal_nervous_system | 1.33178630 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.32270343 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.28544147 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.26455074 |
| 57 | MP0005503_abnormal_tendon_morphology | 1.24422456 |
| 58 | MP0005166_decreased_susceptibility_to | 1.20621107 |
| 59 | MP0000490_abnormal_crypts_of | 1.18365960 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.16032972 |
| 61 | MP0005501_abnormal_skin_physiology | 1.14962367 |
| 62 | MP0001270_distended_abdomen | 1.12308340 |
| 63 | MP0008004_abnormal_stomach_pH | 1.10022668 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 1.09582079 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.07597821 |
| 66 | MP0003195_calcinosis | 1.05459282 |
| 67 | MP0002136_abnormal_kidney_physiology | 1.04568036 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.02855418 |
| 69 | MP0000003_abnormal_adipose_tissue | 1.00955739 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.00845710 |
| 71 | MP0003868_abnormal_feces_composition | 1.00444184 |
| 72 | MP0006082_CNS_inflammation | 1.00255562 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.98958452 |
| 74 | MP0003252_abnormal_bile_duct | 0.97435677 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.96626831 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.94470205 |
| 77 | MP0001191_abnormal_skin_condition | 0.94374602 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.94371762 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.94040448 |
| 80 | MP0008260_abnormal_autophagy | 0.91081724 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 0.90405154 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.90033717 |
| 83 | MP0005360_urolithiasis | 0.88933591 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.87047959 |
| 85 | MP0002098_abnormal_vibrissa_morphology | 0.86787378 |
| 86 | MP0001851_eye_inflammation | 0.86008897 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.85534872 |
| 88 | MP0008469_abnormal_protein_level | 0.84378643 |
| 89 | MP0001663_abnormal_digestive_system | 0.83003263 |
| 90 | MP0005390_skeleton_phenotype | 0.81125725 |
| 91 | MP0005409_darkened_coat_color | 0.79742409 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.79157187 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77816826 |
| 94 | MP0004084_abnormal_cardiac_muscle | 0.74293836 |
| 95 | MP0008057_abnormal_DNA_replication | 0.73200800 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.71433413 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.71092461 |
| 98 | MP0003077_abnormal_cell_cycle | 0.70912058 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.70391148 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 0.69200926 |
| 101 | MP0001919_abnormal_reproductive_system | 0.67068005 |
| 102 | MP0002083_premature_death | 0.66658099 |
| 103 | MP0000377_abnormal_hair_follicle | 0.65786698 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.65576531 |
| 105 | MP0000609_abnormal_liver_physiology | 0.65217921 |
| 106 | MP0000477_abnormal_intestine_morphology | 0.64779281 |
| 107 | MP0002060_abnormal_skin_morphology | 0.64304048 |
| 108 | MP0002168_other_aberrant_phenotype | 0.64060236 |
| 109 | MP0003045_fibrosis | 0.62428241 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.62300526 |
| 111 | MP0001664_abnormal_digestion | 0.62287263 |
| 112 | MP0003075_altered_response_to | 0.61665509 |
| 113 | MP0000604_amyloidosis | 0.61545915 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.57480168 |
| 115 | MP0009931_abnormal_skin_appearance | 0.56536019 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.55368750 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.54922656 |
| 118 | MP0005023_abnormal_wound_healing | 0.51681829 |
| 119 | MP0001666_abnormal_nutrient_absorption | 0.51604089 |
| 120 | MP0000313_abnormal_cell_death | 0.51156599 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.50590575 |
| 122 | MP0005397_hematopoietic_system_phenotyp | 0.49438749 |
| 123 | MP0001545_abnormal_hematopoietic_system | 0.49438749 |
| 124 | MP0000858_altered_metastatic_potential | 0.48262550 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.47742604 |
| 126 | MP0005621_abnormal_cell_physiology | 0.45936374 |
| 127 | MP0009763_increased_sensitivity_to | 0.43772082 |
| 128 | MP0009764_decreased_sensitivity_to | 0.42529895 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.42505782 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.42290033 |
| 131 | MP0005388_respiratory_system_phenotype | 0.42026335 |
| 132 | MP0002133_abnormal_respiratory_system | 0.42026335 |
| 133 | MP0003795_abnormal_bone_structure | 0.39980431 |
| 134 | MP0001730_embryonic_growth_arrest | 0.39335809 |
| 135 | MP0003091_abnormal_cell_migration | 0.37872117 |
| 136 | MP0008873_increased_physiological_sensi | 0.37761328 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.36940838 |
| 138 | MP0000598_abnormal_liver_morphology | 0.36708861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of B cell number (HP:0010975) | 8.10512202 |
| 2 | B lymphocytopenia (HP:0010976) | 8.10512202 |
| 3 | Colitis (HP:0002583) | 7.64429881 |
| 4 | Recurrent sinusitis (HP:0011108) | 7.59547888 |
| 5 | Recurrent bronchitis (HP:0002837) | 7.46132306 |
| 6 | Cellulitis (HP:0100658) | 7.07155652 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 6.58139507 |
| 8 | Verrucae (HP:0200043) | 6.41029431 |
| 9 | Papilloma (HP:0012740) | 6.41029431 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 5.90372505 |
| 11 | Inflammation of the large intestine (HP:0002037) | 5.87701344 |
| 12 | IgM deficiency (HP:0002850) | 5.68826185 |
| 13 | Recurrent viral infections (HP:0004429) | 5.63289439 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 5.61156214 |
| 15 | Recurrent pneumonia (HP:0006532) | 5.50985026 |
| 16 | Decreased circulating renin level (HP:0003351) | 5.47906278 |
| 17 | Chronic sinusitis (HP:0011109) | 5.15058905 |
| 18 | Meningitis (HP:0001287) | 5.12475069 |
| 19 | Recurrent lower respiratory tract infections (HP:0002783) | 4.90693612 |
| 20 | Chronic otitis media (HP:0000389) | 4.64945716 |
| 21 | Malnutrition (HP:0004395) | 4.61742010 |
| 22 | Osteomyelitis (HP:0002754) | 4.44514600 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 4.39327435 |
| 24 | Bronchitis (HP:0012387) | 4.38316312 |
| 25 | Emphysema (HP:0002097) | 4.25502994 |
| 26 | Recurrent otitis media (HP:0000403) | 4.10849174 |
| 27 | IgA deficiency (HP:0002720) | 4.06413257 |
| 28 | Lymphopenia (HP:0001888) | 3.75326315 |
| 29 | Sepsis (HP:0100806) | 3.61367553 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.61247701 |
| 31 | IgG deficiency (HP:0004315) | 3.59492271 |
| 32 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.59361062 |
| 33 | Villous atrophy (HP:0011473) | 3.59361062 |
| 34 | Skin rash (HP:0000988) | 3.55142903 |
| 35 | Nuclear cataract (HP:0100018) | 3.44024773 |
| 36 | Vasculitis (HP:0002633) | 3.37666345 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 3.35651176 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.21348512 |
| 39 | Restrictive lung disease (HP:0002091) | 3.16585658 |
| 40 | Hyperkalemia (HP:0002153) | 3.16310735 |
| 41 | Thyroiditis (HP:0100646) | 3.12739940 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 3.10752644 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02133166 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01391677 |
| 45 | Abnormality of nail color (HP:0100643) | 2.98780989 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.97726180 |
| 47 | Hypokalemic alkalosis (HP:0001949) | 2.90495975 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.88683813 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.86185694 |
| 50 | Nephritis (HP:0000123) | 2.82007534 |
| 51 | Nasal polyposis (HP:0100582) | 2.80950527 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.72239272 |
| 53 | Glomerulonephritis (HP:0000099) | 2.69162951 |
| 54 | Hyperaldosteronism (HP:0000859) | 2.68808995 |
| 55 | Plantar hyperkeratosis (HP:0007556) | 2.68526410 |
| 56 | Alkalosis (HP:0001948) | 2.68393129 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.67427212 |
| 58 | Cone-rod dystrophy (HP:0000548) | 2.65205322 |
| 59 | Palmoplantar hyperkeratosis (HP:0000972) | 2.63011312 |
| 60 | Small epiphyses (HP:0010585) | 2.62843461 |
| 61 | Basal cell carcinoma (HP:0002671) | 2.62323699 |
| 62 | Zonular cataract (HP:0010920) | 2.61561003 |
| 63 | Abnormality of T cells (HP:0002843) | 2.59736999 |
| 64 | Recurrent bacterial skin infections (HP:0005406) | 2.58757797 |
| 65 | Chronic bronchitis (HP:0004469) | 2.58311270 |
| 66 | Abnormality of complement system (HP:0005339) | 2.57198984 |
| 67 | Neutropenia (HP:0001875) | 2.54680967 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48730666 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48730666 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48730666 |
| 71 | Erythema (HP:0010783) | 2.48035528 |
| 72 | Bronchiectasis (HP:0002110) | 2.47547719 |
| 73 | Onycholysis (HP:0001806) | 2.45674736 |
| 74 | Alopecia of scalp (HP:0002293) | 2.44576888 |
| 75 | Hyponatremia (HP:0002902) | 2.43196749 |
| 76 | Renal salt wasting (HP:0000127) | 2.42937619 |
| 77 | Palmar hyperkeratosis (HP:0010765) | 2.41415472 |
| 78 | Leukopenia (HP:0001882) | 2.40025148 |
| 79 | Abnormality of chloride homeostasis (HP:0011422) | 2.39234088 |
| 80 | Complement deficiency (HP:0004431) | 2.37983709 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.35132241 |
| 82 | Skin ulcer (HP:0200042) | 2.33417505 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.33148636 |
| 84 | Adrenal overactivity (HP:0002717) | 2.31549497 |
| 85 | Ankyloglossia (HP:0010296) | 2.30375669 |
| 86 | Eczematoid dermatitis (HP:0000976) | 2.29216683 |
| 87 | Lower limb hyperreflexia (HP:0002395) | 2.28941224 |
| 88 | Hyperparathyroidism (HP:0000843) | 2.27899703 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 2.25444000 |
| 90 | Recurrent skin infections (HP:0001581) | 2.23786487 |
| 91 | Thick nail (HP:0001805) | 2.23468874 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 2.20638028 |
| 93 | Thrombocytosis (HP:0001894) | 2.20082306 |
| 94 | Urticaria (HP:0001025) | 2.19855076 |
| 95 | Myositis (HP:0100614) | 2.18514571 |
| 96 | Lymphoma (HP:0002665) | 2.18366053 |
| 97 | Increased IgE level (HP:0003212) | 2.17865030 |
| 98 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.15414063 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12439663 |
| 100 | Pustule (HP:0200039) | 2.11087270 |
| 101 | Squamous cell carcinoma (HP:0002860) | 2.09580905 |
| 102 | Abnormal tarsal ossification (HP:0008369) | 2.08368812 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07304402 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07304402 |
| 105 | Mitral stenosis (HP:0001718) | 2.07191881 |
| 106 | Autoimmune thrombocytopenia (HP:0001973) | 2.04745570 |
| 107 | Esophageal neoplasm (HP:0100751) | 2.04065639 |
| 108 | Neoplasm of head and neck (HP:0012288) | 2.04065639 |
| 109 | Dehydration (HP:0001944) | 2.01707229 |
| 110 | Parakeratosis (HP:0001036) | 2.00235594 |
| 111 | Agammaglobulinemia (HP:0004432) | 10.5038689 |
| 112 | Dry hair (HP:0011359) | 1.97515956 |
| 113 | Hypercortisolism (HP:0001578) | 1.94289999 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92825677 |
| 115 | Abnormality of T cell number (HP:0011839) | 1.92773786 |
| 116 | Hypotension (HP:0002615) | 1.91324225 |
| 117 | Xerostomia (HP:0000217) | 1.91159562 |
| 118 | Gingivitis (HP:0000230) | 1.90114322 |
| 119 | Viral hepatitis (HP:0006562) | 1.89783192 |
| 120 | Obstructive lung disease (HP:0006536) | 1.89536512 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89536512 |
| 122 | Abnormality of macrophages (HP:0004311) | 1.88770156 |
| 123 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.87748430 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.87555132 |
| 125 | Nonimmune hydrops fetalis (HP:0001790) | 1.87241387 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.85845946 |
| 127 | Rhabdomyolysis (HP:0003201) | 1.85629757 |
| 128 | Exocrine pancreatic insufficiency (HP:0001738) | 1.84627463 |
| 129 | Prostate neoplasm (HP:0100787) | 1.83463163 |
| 130 | Loss of speech (HP:0002371) | 1.82109847 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.81273571 |
| 132 | T lymphocytopenia (HP:0005403) | 1.81250525 |
| 133 | Encephalitis (HP:0002383) | 1.79650456 |
| 134 | Arthralgia (HP:0002829) | 1.78632980 |
| 135 | Flattened epiphyses (HP:0003071) | 1.78059304 |
| 136 | Teleangiectasia of the skin (HP:0100585) | 1.69379718 |
| 137 | Abnormality of the fingertips (HP:0001211) | 1.67737479 |
| 138 | Conical tooth (HP:0000698) | 1.64558570 |
| 139 | Vacuolated lymphocytes (HP:0001922) | 1.63468562 |
| 140 | Combined immunodeficiency (HP:0005387) | 1.58827647 |
| 141 | Microcytic anemia (HP:0001935) | 1.55372975 |
| 142 | Premature loss of primary teeth (HP:0006323) | 1.55296437 |
| 143 | External ear malformation (HP:0008572) | 1.54663896 |
| 144 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.50969774 |
| 145 | Myocardial infarction (HP:0001658) | 1.50025995 |
| 146 | Petechiae (HP:0000967) | 1.50021725 |
| 147 | Severe combined immunodeficiency (HP:0004430) | 1.44861379 |
| 148 | Chronic diarrhea (HP:0002028) | 1.43419199 |
| 149 | Irregular vertebral endplates (HP:0003301) | 1.40076355 |
| 150 | Ridged nail (HP:0001807) | 1.38388524 |
| 151 | Blepharitis (HP:0000498) | 1.35144514 |
| 152 | Eosinophilia (HP:0001880) | 1.33265037 |
| 153 | Seborrheic dermatitis (HP:0001051) | 1.32140647 |
| 154 | Macroorchidism (HP:0000053) | 1.30281482 |
| 155 | Abnormality of incisor morphology (HP:0011063) | 1.26848481 |
| 156 | Fatigue (HP:0012378) | 1.24971644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.99074366 |
| 2 | MAP4K1 | 5.88330743 |
| 3 | PRPF4B | 4.28680441 |
| 4 | NME2 | 3.81465376 |
| 5 | GRK6 | 3.03827261 |
| 6 | CSF1R | 2.89993896 |
| 7 | MAP3K10 | 2.89479138 |
| 8 | SYK | 2.86524907 |
| 9 | BLK | 2.73260657 |
| 10 | TBK1 | 2.47295223 |
| 11 | RIPK4 | 2.40689501 |
| 12 | MAP3K14 | 2.40427754 |
| 13 | TYK2 | 2.26600894 |
| 14 | MAP3K13 | 2.13145108 |
| 15 | KIT | 1.99676002 |
| 16 | EIF2AK3 | 1.98870634 |
| 17 | TAOK3 | 1.96206853 |
| 18 | BTK | 1.92011913 |
| 19 | LYN | 1.71931368 |
| 20 | IKBKE | 1.68954961 |
| 21 | IRAK3 | 1.51993364 |
| 22 | PRKCH | 1.50405539 |
| 23 | RIPK1 | 1.48634044 |
| 24 | STK24 | 1.45024953 |
| 25 | MST1R | 1.35251246 |
| 26 | IRAK4 | 1.34107014 |
| 27 | MARK2 | 1.30547584 |
| 28 | PKN2 | 1.27542596 |
| 29 | SIK2 | 1.25721082 |
| 30 | LRRK2 | 1.23211363 |
| 31 | IKBKB | 1.18903710 |
| 32 | NEK2 | 1.18887428 |
| 33 | EPHA2 | 1.18176120 |
| 34 | HCK | 1.14608074 |
| 35 | PRKCQ | 1.13210593 |
| 36 | STK10 | 1.09511893 |
| 37 | MST4 | 1.08716373 |
| 38 | MAP3K9 | 1.07893144 |
| 39 | JAK1 | 1.07131557 |
| 40 | ITK | 1.05231289 |
| 41 | MET | 1.04988564 |
| 42 | TEC | 1.04828773 |
| 43 | JAK3 | 1.02248087 |
| 44 | PRKCI | 0.98236418 |
| 45 | DYRK1B | 0.94709014 |
| 46 | MATK | 0.94298630 |
| 47 | ARAF | 0.93767776 |
| 48 | LCK | 0.92907235 |
| 49 | MAP3K1 | 0.90925268 |
| 50 | NEK9 | 0.90630143 |
| 51 | FES | 0.87430143 |
| 52 | CSK | 0.84540189 |
| 53 | HIPK2 | 0.84150788 |
| 54 | EIF2AK1 | 0.81346521 |
| 55 | BCKDK | 0.81237767 |
| 56 | PIM1 | 0.80883887 |
| 57 | RPS6KA4 | 0.78304782 |
| 58 | SMG1 | 0.78144255 |
| 59 | PAK4 | 0.78114275 |
| 60 | PTK2 | 0.75889861 |
| 61 | CLK1 | 0.74491172 |
| 62 | FRK | 0.71601461 |
| 63 | CDC42BPA | 0.70302666 |
| 64 | CCNB1 | 0.68240377 |
| 65 | YES1 | 0.66755562 |
| 66 | FGFR3 | 0.65382704 |
| 67 | EEF2K | 0.64763001 |
| 68 | ZAP70 | 0.64412107 |
| 69 | TGFBR2 | 0.59447188 |
| 70 | EPHA3 | 0.55164898 |
| 71 | BRD4 | 0.54013864 |
| 72 | TESK2 | 0.52721037 |
| 73 | CHUK | 0.52563388 |
| 74 | PDK1 | 0.52184340 |
| 75 | GRK1 | 0.52105449 |
| 76 | PIK3CG | 0.50530291 |
| 77 | TXK | 0.49176579 |
| 78 | FGFR4 | 0.49147676 |
| 79 | ACVR1B | 0.48816848 |
| 80 | MAPK7 | 0.48608117 |
| 81 | CDK6 | 0.46405800 |
| 82 | FYN | 0.45950097 |
| 83 | TRIB3 | 0.45544978 |
| 84 | PRKCD | 0.44424437 |
| 85 | CDK19 | 0.43986298 |
| 86 | BMX | 0.42388538 |
| 87 | MAP2K2 | 0.41790193 |
| 88 | ALK | 0.41614491 |
| 89 | SIK1 | 0.41402790 |
| 90 | TAOK1 | 0.41215962 |
| 91 | SIK3 | 0.41202722 |
| 92 | MAPK11 | 0.39422577 |
| 93 | JAK2 | 0.39390192 |
| 94 | CDK4 | 0.39245834 |
| 95 | BUB1 | 0.39071083 |
| 96 | MAPK12 | 0.39068520 |
| 97 | INSR | 0.38547862 |
| 98 | SCYL2 | 0.38543428 |
| 99 | KSR2 | 0.38463045 |
| 100 | MAP3K11 | 0.38214440 |
| 101 | PDPK1 | 0.37623341 |
| 102 | PIM2 | 0.36463567 |
| 103 | ABL1 | 0.35974537 |
| 104 | SGK3 | 0.35763525 |
| 105 | MAPK3 | 0.35058142 |
| 106 | BRAF | 0.34323055 |
| 107 | CDK3 | 0.34303619 |
| 108 | RPS6KL1 | 0.33489248 |
| 109 | RPS6KC1 | 0.33489248 |
| 110 | MARK3 | 0.33485455 |
| 111 | MAP2K6 | 0.33357318 |
| 112 | RAF1 | 0.32541890 |
| 113 | PRKD1 | 0.32216272 |
| 114 | MAP2K3 | 0.31496980 |
| 115 | CDC7 | 0.30783397 |
| 116 | MAP3K8 | 0.30323996 |
| 117 | IRAK1 | 0.28569314 |
| 118 | LMTK2 | 0.27920323 |
| 119 | PRKD2 | 0.27849975 |
| 120 | PRKAA2 | 0.27520057 |
| 121 | CDK9 | 0.26721589 |
| 122 | CHEK2 | 0.26354373 |
| 123 | STK4 | 0.26286502 |
| 124 | MAP3K3 | 0.26238041 |
| 125 | MAP3K7 | 0.26174522 |
| 126 | EGFR | 0.26040603 |
| 127 | MAPK4 | 0.25874837 |
| 128 | TNK2 | 0.25742957 |
| 129 | PIK3CA | 0.25446487 |
| 130 | SGK2 | 0.25155855 |
| 131 | PKN1 | 0.24503846 |
| 132 | TLK1 | 0.22309768 |
| 133 | EPHB1 | 0.20587656 |
| 134 | CSNK1A1L | 0.19855763 |
| 135 | FLT3 | 0.19826518 |
| 136 | MAPKAPK2 | 0.19255003 |
| 137 | CDK12 | 0.18713827 |
| 138 | MELK | 0.17558862 |
| 139 | RPS6KB2 | 0.16988309 |
| 140 | FGR | 0.16552428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 6.84082739 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.34871798 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.91913354 |
| 4 | Protein export_Homo sapiens_hsa03060 | 4.39889432 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.31304861 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.25473730 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.56460731 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.49648689 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29235700 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.12758402 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.77162034 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.71188281 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.64117080 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64100935 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.62994500 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59894170 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57975107 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56029636 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49488521 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.43391151 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41408967 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.37585591 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35081378 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32749006 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31144641 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.23509202 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14323751 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.10136861 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.08378386 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05722719 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04306020 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02208871 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.01519064 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00855004 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00555110 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.00187808 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00041580 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99183630 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95975392 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95197879 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89388858 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89318753 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 0.88418197 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87375334 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83199722 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.82516480 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82487843 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81808018 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79713185 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.79465008 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77612761 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76561297 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76054679 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75832789 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75120197 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71960266 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.71411568 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70151115 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70053574 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69218793 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.68792855 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68630410 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.68610604 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.68104350 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66774668 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66233967 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64410927 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64282860 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63481879 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.63330968 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.61884593 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61162387 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60713294 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59873744 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.59334149 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59114173 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.58287901 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57718471 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57701688 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57660382 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57239992 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.52890845 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50342603 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49983257 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49251678 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48897100 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47675206 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.47442967 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47306364 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46982362 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46368487 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46067785 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45715770 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45435224 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44438503 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43742889 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43032071 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42638005 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.41864877 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41512408 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40401480 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39891412 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39788001 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37352174 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.37308262 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37284654 |
| 107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35863202 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35744126 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35506045 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35085867 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33688358 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33612462 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32505367 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32258914 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32073962 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31851227 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29820775 |
| 118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28971401 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27670256 |
| 120 | Spliceosome_Homo sapiens_hsa03040 | 0.25511083 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25178738 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21884896 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.21456598 |
| 124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20591760 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.20224786 |
| 126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17716710 |
| 127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.17211974 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16813197 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15452561 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.15039649 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.14693339 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.13528168 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.11710624 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10767859 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10504159 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.10376894 |
| 137 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.10291235 |

